ETR:SBS Stratec (SBS) Stock Price, News & Analysis €25.85 -0.80 (-3.00%) As of 08/22/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesBuy This Stock About Stratec Stock (ETR:SBS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Stratec alerts:Sign Up Key Stats Today's Range€25.60▼€26.8550-Day Range€23.45▼€29.4052-Week Range€36.00▼€49.65Volume20,726 shsAverage Volume6,253 shsMarket Capitalization€310.55 millionP/E Ratio31.02Dividend Yield2.13%Price TargetN/AConsensus RatingN/A Company Overview Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany. Read More Receive SBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stratec and its competitors with MarketBeat's FREE daily newsletter. Email Address SBS Stock News HeadlinesStratec SE (ETR:SBS) Just Reported Earnings, And Analysts Cut Their Target PriceAugust 23 at 5:13 AM | finance.yahoo.comStratec SE (XTER:SBS) (H1 2025) Earnings Call Highlights: Navigating Growth and ChallengesAugust 20, 2025 | gurufocus.comTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.August 24 at 2:00 AM | American Alternative (Ad)Owning 42% shares,institutional owners seem interested in Stratec SE (ETR:SBS),July 30, 2025 | finance.yahoo.comStratec SE's (ETR:SBS) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?July 8, 2025 | finance.yahoo.comStratec (ETR:SBS) shareholders have endured a 73% loss from investing in the stock three years agoJune 22, 2025 | finance.yahoo.comStratec Full Year 2024 Earnings: EPS Beats ExpectationsMay 21, 2025 | finance.yahoo.comStratec SE (SBS.BE)April 13, 2025 | uk.finance.yahoo.comSee More Headlines SBS Stock Analysis - Frequently Asked Questions How have SBS shares performed this year? Stratec's stock was trading at €29.80 at the start of the year. Since then, SBS shares have decreased by 13.3% and is now trading at €25.85. What other stocks do shareholders of Stratec own? Based on aggregate information from My MarketBeat watchlists, some other companies that Stratec investors own include Great Portland Estates (GPOR), Gogo (GOGO), Depomed (DEPO), Cenovus Energy (CVE), China Hydroelectric Corp Foreign (CHC), Bio-Rad Laboratories (BIO) and Berkshire Hills Bancorp (BHLB). Industry, Sector and Symbol Stock ExchangeETR SectorMedical Industry Medical Devices Sub-IndustryUtilities Current SymbolETR:SBS CIKN/A Webwww.stratec.com Phone+49-7082-79160FaxN/AEmployees1,464Year FoundedN/AProfitability EPS (Trailing Twelve Months)€0.83 Trailing P/E Ratio31.02 Forward P/E Ratio7.18 P/E Growth10.43Net Income€9.89 million Net Margins4.00% Pretax MarginN/A Return on Equity4.36% Return on Assets4.09% Debt Debt-to-Equity Ratio66.97 Current Ratio2.52 Quick Ratio1.65 Sales & Book Value Annual Sales€247.60 million Price / Sales1.25 Cash Flow€1.08 per share Price / Cash Flow23.85 Book Value€18.74 per share Price / Book1.38Miscellaneous Outstanding Shares12,013,727Free FloatN/AMarket Cap€310.55 million OptionableNot Optionable Beta0.16 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (ETR:SBS) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersCould This Be the End of Retirement Worries?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stratec SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Stratec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access